Terveys, väestönmuutos ja
hyvinvointi Horisontti 2020
ohjelmassa
Tästä se lähtee – Tietoa Horisontti 2020 rahoituksesta
(Otaniemi, 27.11.2013)
Hannu Lång, Unit of Infectious Diseases & Public Health, Health Directorate
Directorate-General for Research and Innovation
European Commission
Research and
Innovation
Esityksen pääkohdat
FP7: Suomen menestys
edellisessä puiteohjelmassa
Horisontti 2020:–ohjelman ydin
Terveys, väestönmuutos ja
hyvinvointi : Työohjelma 20142015.
Research and
Innovation
 Health
EU RTD Landscape




•Alzheimer
•Agriculture, Food Security
& Climate change
•Health and Diet
•Cultural Heritage


ERANET+
ERANET

 
Ageing (More Years Better Lives)
Climate Knowledge (Clik-EU)
Seas and Oceans
Antimicrobial resistance
Urban Europe
Water challenges
JTI Artemis Eniac
Clean Sky IMI FCH
 


ICT-FET (Flag Ships)
Fundamental
Research
ERC




JTI PPP
SMEs and SME Associations
PEOPLE
Development


eHealth
eIdentity
ICT for TT
Energy efficiency
A Pilots
PPP

Energy Efficient Buildings
Future of Factories
Smart grid & Utilities
Green cars
Future Internet TT, mobility & logistics
Content
Environment & Smart Food
Safe Cities
Large Scale Demos & Trials
Innovation
Deployment
Market set up
15/02/2011
* EERP – European Energy Recovery Plan
XII/2010 8IPx5M€x2 years
NER300 – New Entrants Reserve 300 Million Tons
Research and
X/2012 5IPx13,5 M€x2
years demonstration site
Innovation
Autor: Serafín de la Concha (CDTI)
EII on
Energy
EUROSTARS
INFRASTRUCTURES
Applied
Research


Art. 185 AAL
Bonus EMRP,
EDCTP
Programmes Wind EWI ≈6B€
Instruments Solar SEII ≈16B€
Bioenergy EIBI≈9 B€
New thematic Carbon Capture & Storage ≈13B€
initiatives
Electricity Grid EEGI≈ 2 B€
Sustainable Nuclear ESNII ≈10 B€
Smart Cities (E2B+TT+Grid)≈11B€
Suomalaisten menestys FP7
Research and
Innovation
Research and
Innovation
Research and
Innovation
Research and
Innovation
Horisontti 2020 pähkinänkuoressa
Research and
Innovation
Mikä on Horisontti 2020
• €70 miljardia EUn tutkimukseen ja
innovaatioon 2014-2020
• Ydinosa 'Europe 2020, Innovation Union &
European Research Area':
− Vastaus talouskriisiin; investointi
tulevaisuuden työpaikkoihin ja kasvuun
− Vastaus ihmisten huoleen toimeentulosta,
turvallisuudesta ja ympäristöstä
− EU’s globaalisen aseman vahvistaminen
tutkimuksessa, innovaatiossa ja teknologiassa
Research and
Innovation
Mitä on uutta?
• Yksi ohjelma
tuo yhteen kolme erillistä
ohjelmaa/aloitetta*
• Tutkimuksen ja innovaation kytkentä
–
tutkimuksesta myyntiin, innovaatio laajasti ymmärrettynä
• Polttopisteessä yhteiskunnalliset haasteet
esim. terveys, puhdas energia ja liikenne
• Yksinkertaistettu hakumenettely, kaikille
yrityksille, yliopistoille, instituuteille EU maissa ja muualla
⃰ The 7th Research Framework Programme (FP7), innovation aspects of
Competitiveness and Innovation Framework Programme (CIP), EU
contribution to the European Institute of Innovation and Technology (EIT)
Research and
Innovation
Mitä muuta on uutta?
• Uusi tasapaino luottamuksen ja kontrollin
välillä – vähemmän tilintarkastuksia
• Rahoitussopimuksilla yksinkertaisemmat
säännöt
• Sivukulut lasketaan kaikille samoin (25%)
• Uusia rahoitusmuotoja innovaatioon ja PKyrityksille
• Nopeampi hakemusten arviointi ja
sopimusneuvottelu (< 8kk)
Research and
Innovation
Helpot sopimukset:
100% kuluista korvataan (paitsi
What else is new
innovaatiotoimissa, joissa 70%
max korvataan voittoa tekevissä
• New balance between
trust and control –
osallistujissa)
fewer audits
Sivukulut: 25% hyväksyttävistä
suorista
kustannuksista
• Simpler rules for
grants
• Indirect costs calculated with a single flat
rate
• New forms of funding aimed at innovation
and focused funding for SMEs
• Successful projects up and running more
quickly
Research and
Innovation
UUsi 'PK instrumentti'
~5 miljardia EUR H2020ssa
What else is new
US "SBIR" mallin inspiroima
Haasteiden ohjaama, 'bottom up'
• New balance between
trust and control –
fewer audits Yksittäinen yritys voi saada
rahoituksen:
• Simpler rules for
grants
3 vaihetta
/ 3 entry points:
Konseptin arviointi,
ja flat
• Indirect costs calculated
with atutkimus
single
innovaatio demonstrointi,
rate
kaupallistaminen
• New forms of funding aimed at innovation
and focused funding for SMEs
• Successful projects up and running more
quickly
Research and
Innovation
Eurooppa 2020
prioriteetit
Yhteiset tavoitteet ja periaatteet
Samat säännöt, työkalupakki rahoitusmuodoille
Yhteiskunnalliset
haasteet
Tutkimuksen
ohjaamat
projektit
Teollisuuden
johtoasema
Huipputason
tiede
Tavoitteiden tukeminen:
EIT
JRC
Research and
Innovation
Markkinoiden
ohjaamat
projektit
Laajat hakuaiheet
Vähemmän yksityiskohtia
hakuaiheissa
Horisontaaliset hakuaiheet
Kaksivuotinen työohjelma
Suurempi paino loppukäyttäjillä
Research and
Innovation
Recap: the 'Health, demographic change and
wellbeing' challenge
Proposed funding 2014-2020 (million EUR)
Research and
Innovation
The Work Programme 2014/15 in brief
Call 'personalising health and care'
34 topics (15 in 2014, 17 in 2015, 2 open in both years)
Call for 'co-ordination activities'
16 topics (11 in 2014, 5 in 2015)
€ 1,21
billion
Research and
Innovation
7 Focus Areas
Understanding health, ageing & disease
Effective health promotion, disease prevention,
preparedness and screening
Improving diagnosis
Innovative treatments and technologies
Advancing active and healthy ageing
Integrated, sustainable, citizen-centred care
Improving health information, data exploitation and
providing an evidence base for health policies and regulation
Research and
Innovation
Understanding the call topics: example
• 'PHC 2 – 2015'
• 'Specific
challenge'
• 'Scope'
• 'Expected impact'
• 'Type of action'
Research and
Innovation
Personalising
Health and Care
Research and
Innovation
Unravelling health and disease
• Determinants, risk factors and pathways of
diseases (2014)
•
Determinants and pathways of healthy
and active ageing (2014)
• Systems medicine approaches (2015)
• Common mechanisms of diseases and
potential co-morbidities (2015)
Research and
Innovation
From "omics" … to prevention
•
Inter-sector cooperation for environment- and healthbased interventions (2015)
•
Translating -omics into prevention and health promotion
(2014)
•
Evaluating existing screening and prevention programmes
(2014)
•
Control of infectious epidemics through rapid pathogen
identification (2014)
•
Vaccine platforms for TB (2014) and HIV (2015)
Research and
Innovation
In biomarkers we trust …
and in novel diagnostic tools
• In vitro devices, assays and platforms (2014)
• In vivo medical imaging technologies (2015)
• Clinical validation of biomarkers (2014,
2015)
• SME focus
Research and
Innovation
Finding the cure …
and evaluating existing
treatments
• Therapies for non-communicable diseases
(2014) and rare diseases (2015)
• Tools and technologies for advanced
therapies (2015)
• Clinical research on regenerative medicine
(2014)
• Comparing and establishing effectiveness of
health interventions in the elderly (2014)
and children (2015)
Research and
Innovation
Adding more life to our years
• Service robotics within assisted living
environments (2014)
• Solutions for independent living (2014)
• Early risk detection and intervention (2015)
• Promoting mental wellbeing in the ageing
population (2015)
Research and
Innovation
•
•
The citizen in the centre
New models for prevention oriented health and care
systems (2014)
•
Piloting personalised medicine in health and care systems
(2015)
•
Self-management of health and disease: mHealth, ICT,
decision support systems
•
Public procurement and eHealth
•
eHealth sectorial inducement prize
Research and
Innovation
•
•
The citizen in the centre (2)
ICT systems for integrated care (2015)
•
Citizen support and mHealth (2014)
•
Self-management by predictive computer modelling
(2015)
•
Patient empowerment by ICT (2015)
•
Public procurement and eHealth (2015)
Research and
Innovation
Big Data for research
• Digital representation of health data to improve
diagnosis and treatment (2015)
• Foresight for health policy development and
regulation (2014)
• Advancing bioinformatics for clinical needs
(2014)
• Improve predictive human safety testing (2015)
• eHealth interoperability (2014)
Research and
Innovation
Co-ordination
activities
Research and
Innovation
Support for European and
International Initiatives
• European Innovation Partnership on Active and
Healthy Ageing
• Global Alliance for Chronic Diseases (GACD) –
Diabetes (2014)
• Joint Programming Initiative 'More Years,
Better Life's (2014)
• Joint Programming Initiative on
neurodegenerative diseases (JPND, 2014)
• Global Research Collaboration for Infectious
Disease Preparedness (2014)
• European Reference Networks (2015)
Research and
Innovation
Completing the European
Research Area
• Joint Programming Initiative on
neurodegenerative diseases (JPND, 2014)
• Translational cancer research (2014)
• Systems medicine for clinical needs (2014)
• Rare diseases (2014)
• 2015: Brain-related disorders, antimicrobial
resistance, cardiovascular diseases
Research and
Innovation
Strategic Initiatives
Innovative Medicines
Initiative 2
www.imi.europa.eu
European Innovation Partnership
on Active and Healthy Ageing
https://webgate.ec.europa.eu/eip
aha
Active and Assisted Living 2
www.aal-europe.eu
European & Developing Countries
Clinical Trials Partnership
(EDCTP2)
www.edctp.org
Research and
Innovation
Thank you
[email protected]
www.ec.europa/research/horizon2020
Research and
Innovation